Although CTLA-4 is a relevant target for enhancing effector responses in some tumor models [103,108], blockade of CTLA-4 leads to enhanced costimulatory signals and hyperproliferation of Treg cells, resulting in increased immune tolerance [108]. The gene discussed is CTLA4; the disease is neoplasm.